Hindustan Bio Sciences Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported total income from operations (net) of INR 2.250 million compared to INR 9.276 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 1.056 million compared to INR 0.468 million a year ago. Loss from ordinary activities before tax was INR 1.124 million compared to INR 0.536 million a year ago. Net loss for the period was INR 1.124 million or INR 0.11 per basic and diluted share compared to INR 0.536 million or INR 0.05 per basic and diluted share a year ago.

For the nine months, the company reported total income from operations (net) of INR 5.957 million compared to INR 19.243 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 11.983 million compared to INR 5.684 million a year ago. Loss from ordinary activities before tax was INR 12.220 million compared to INR 5.875 million a year ago. Net loss for the period was INR 12.220 million or INR 1.19 per basic and diluted share compared to INR 5.875 million or INR 0.57 per basic and diluted share a year ago.